{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:23Z","timestamp":1789635743893,"version":"4.0.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Science and Technology, Govt. of India","award":["SR\/SO\/HS-0113\/2010"],"award-info":[{"award-number":["SR\/SO\/HS-0113\/2010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02106-z","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:49:48Z","timestamp":1782373788000},"page":"4089-4103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Epithelial-to-Mesenchymal Transition Related Markers With Clinical Outcome in Non-Muscle Invasive and Muscle Invasive Bladder Cancer Patients"],"prefix":"10.1007","volume":"84","author":[{"given":"R","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singh","family":"UP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"2106_CR1","doi-asserted-by":"publisher","unstructured":"Nasrallah, A. A., & Williams, S. B. (2024). Epidemiology of Bladder Cancer. In: Knowles, M.A., Dyrskj\u00f8t, L. (Eds.) Biology of Bladder Cancer. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-68505-7_1","DOI":"10.1007\/978-3-031-68505-7_1"},{"key":"2106_CR2","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1038\/s41598-025-92033-5","volume":"15","author":"X Su","year":"2025","unstructured":"Su, X., Tao, Y., Chen, F., Han, X., Xue, & Li (2025). Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021. Scientific Reports, 15, 7655. https:\/\/doi.org\/10.1038\/s41598-025-92033-5","journal-title":"Scientific Reports"},{"issue":"4","key":"2106_CR3","first-page":"301","volume":"10","author":"M Garg","year":"2014","unstructured":"Garg, M. (2014). Prognostic and therapeutic applications of the molecular events in clinical management of urothelial carcinoma of bladder. Journal of Experimental and Therapeutic Oncology, 10(4), 301\u2013316. PMID: 25509986.","journal-title":"Journal of Experimental and Therapeutic Oncology"},{"issue":"4","key":"2106_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10555-015-9589-6","volume":"34","author":"M Garg","year":"2015","unstructured":"Garg, M. (2015). Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer And Metastasis Reviews, 34(4), 691\u2013670. https:\/\/doi.org\/10.1007\/s10555-015-9589-6","journal-title":"Cancer And Metastasis Reviews"},{"issue":"1","key":"2106_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA Cancer J clin, 70(1), 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J clin"},{"key":"2106_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41580-024-00733-z","volume":"25","author":"KK Youssef","year":"2024","unstructured":"Youssef, K. K., & Nieto, M. A. (2024). Epithelial\u2013mesenchymal transition in tissue repair and degeneration. Nature Reviews Molecular Cell Biology, 25, 720\u2013739. https:\/\/doi.org\/10.1038\/s41580-024-00733-z","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"5","key":"2106_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"key":"2106_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41556-023-01228-3","volume":"26","author":"Y Sun","year":"2024","unstructured":"Sun, Y., & Ma, L. (2024). A milestone in epithelial\u2013mesenchymal transition. Nature Cell Biology, 26, 29\u201330. https:\/\/doi.org\/10.1038\/s41556-023-01228-3","journal-title":"Nature Cell Biology"},{"issue":"1","key":"2106_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14728222.2018.1407312","volume":"22","author":"M Garg","year":"2018","unstructured":"Garg, M. (2018). Epithelial plasticity and metastatic Cascade. Expert OpinTherTargets, 22(1), 5\u20137. https:\/\/doi.org\/10.1080\/14728222.2018.1407312","journal-title":"Expert OpinTherTargets"},{"issue":"656","key":"2106_CR10","doi-asserted-by":"publisher","first-page":"eabn7571","DOI":"10.1126\/scitranslmed.abn7571","volume":"14","author":"EM Grasset","year":"2022","unstructured":"Grasset, E. M., Dunworth, M., Sharma, G., Loth, M., Tandurella, J., Cimino-Mathews, A., Gentz, M., Bracht, S., Haynes, M., Fertig, E. J., & Ewald, A. J. (2022). Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin. Science Translational Medicine, 14(656), eabn7571. https:\/\/doi.org\/10.1126\/scitranslmed.abn7571","journal-title":"Science Translational Medicine"},{"issue":"100112","key":"2106_CR11","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.adcanc.2023.100112","volume":"9","author":"R Singh","year":"2023","unstructured":"Singh, R., Maurya, N., Tripathi, K., Singh, U. P., Agrawal, V., Goel, A., Singhai, A., Kumar, N., & Garg, M. (2023). Pilot study on quantifying the epithelial\/mesenchymal hybrid state in the non-muscle invasive and muscle invasive bladder tumors: A promising marker of diagnosis and prognosis. Advances in Cancer Biology-Metastasis, 9(100112), 2667\u20133940. https:\/\/doi.org\/10.1016\/j.adcanc.2023.100112","journal-title":"Advances in Cancer Biology-Metastasis"},{"issue":"8","key":"2106_CR12","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.urolonc.2012.02.001","volume":"31","author":"K Wu","year":"2013","unstructured":"Wu, K., Zeng, J., Zhou, J., Fan, J., Chen, Y., Wang, Z., Zhang, T. T., Wang, X., & He, D. (2013). Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Urologic Oncology, 31(8), 1751\u20131760. https:\/\/doi.org\/10.1016\/j.urolonc.2012.02.001","journal-title":"Urologic Oncology"},{"issue":"10","key":"2106_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"CY Loh","year":"2019","unstructured":"Loh, C. Y., Chai, J. Y., Tang, T. F., Wong, W. F., Sethi, G., Shanmugam, M. K., Chong, P. P., & Looi, C. Y. (2019). The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: Signaling, therapeutic implications, and challenges. Cells, 8(10), 1118. https:\/\/doi.org\/10.3390\/cells8101118","journal-title":"Cells"},{"key":"2106_CR14","doi-asserted-by":"publisher","unstructured":"Soares, I. G., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A. (2020). EMT factors and metabolic pathways in cancer. Frontiers in Oncology, 10(499). https:\/\/doi.org\/10.3389\/fonc.2020.00499","DOI":"10.3389\/fonc.2020.00499"},{"issue":"19","key":"2106_CR15","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3390\/cancers13194985","volume":"13","author":"S Usman","year":"2021","unstructured":"Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M. T., & Waseem, A. (2021). Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis. Cancers (Basel), 13(19), 4985. https:\/\/doi.org\/10.3390\/cancers13194985","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2106_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4252\/wjsc.v5.i4.188","volume":"5","author":"M Garg","year":"2013","unstructured":"Garg, M. (2013). Epithelial-mesenchymal transition \u2013 activating transcription factors \u2013 multifunctional regulators in cancer. World Journal of Stem Cells, 5(4), 188\u2013195. https:\/\/doi.org\/10.4252\/wjsc.v5.i4.188","journal-title":"World Journal of Stem Cells"},{"issue":"1","key":"2106_CR17","doi-asserted-by":"publisher","first-page":"BSR20211754","DOI":"10.1042\/BSR20211754","volume":"42","author":"P Debnath","year":"2022","unstructured":"Debnath, P., Huirem, R. S., Dutta, P., & Palchaudhuri, S. (2022). Epithelial\u2013mesenchymal transition and its transcription factors. Bioscience Reports, 42(1), BSR20211754. https:\/\/doi.org\/10.1042\/BSR20211754","journal-title":"Bioscience Reports"},{"key":"2106_CR18","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1038\/modpathol.2009.1","volume":"22","author":"L Cheng","year":"2009","unstructured":"Cheng, L., Montironi, R., Davidson, D. D., & Lopez-Beltran, A. (2009). Staging and reporting of urothelial carcinoma of the urinary bladder. Modern Pathology, 22, S70\u2013S95. https:\/\/doi.org\/10.1038\/modpathol.2009.1","journal-title":"Modern Pathology"},{"issue":"2","key":"2106_CR19","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.clgc.2016.07.021","volume":"15","author":"R Singh","year":"2017","unstructured":"Singh, R., Ansari, J. A., Maurya, N., Mandhani, A., Agrawal, V., & Garg, M. (2017). Epithelial-to-mesenchymal transition and its correlation with clinicopathological features in patients with urothelial carcinoma of the bladder. Clinical Genitourinary Cancer, 15(2), e187\u2013e197. https:\/\/doi.org\/10.1016\/j.clgc.2016.07.021","journal-title":"Clinical Genitourinary Cancer"},{"key":"2106_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13000-019-0868-3","volume":"14","author":"V Kvikstad","year":"2019","unstructured":"Kvikstad, V., Mangrud, O. M., Gudlaugsson, E., Dalen, I., Espeland, H., Baak, J. P. A., & Janssen, E. A. M. (2019). Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas. DiagnPathol, 14, 90. https:\/\/doi.org\/10.1186\/s13000-019-0868-3","journal-title":"DiagnPathol"},{"key":"2106_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41746-024-01003-0","volume":"7","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Yang, Z., Chen, R., Zhu, Y., Liu, L., Dong, J., Zhang, Z., Sun, X., Ying, J., Lin, D., Yang, L., & Zhou, M. (2024). Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. npj Digit Med, 7, 15. https:\/\/doi.org\/10.1038\/s41746-024-01003-0","journal-title":"npj Digit Med"},{"issue":"17","key":"2106_CR22","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3390\/cancers16173056","volume":"16","author":"G Dimitrov","year":"2024","unstructured":"Dimitrov, G., Mangaldzhiev, R., Slavov, C., & Popov, E. (2024). Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review. Cancers, 16(17), 3056. https:\/\/doi.org\/10.3390\/cancers16173056","journal-title":"Cancers"},{"key":"2106_CR23","doi-asserted-by":"publisher","first-page":"62489","DOI":"10.18632\/oncotarget.19934","volume":"8","author":"Y Xie","year":"2017","unstructured":"Xie, Y., Li, P., Gao, Y., Gu, L., Chen, L., Fan, Y., Zhang, F., & Zhang, X. (2017). Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis. Oncotarget, 8, 62489\u201362499. https:\/\/www.oncotarget.com\/article\/19934\/text\/","journal-title":"Oncotarget"},{"key":"2106_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-06-2330","volume":"13","author":"E Baumgart","year":"2007","unstructured":"Baumgart, E., Cohen, M. S., Silva Neto, B., Jacobs, M. A., Wotkowicz, C., Rieger-Christ, K. M., Biolo, A., Zeheb, R., Loda, M., Libertino, J. A., & Summerhayes, I. C. (2007). Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clinical Cancer Research, 13, 1685\u20131694. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2330","journal-title":"Clinical Cancer Research"},{"key":"2106_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopha.2018.11.112","volume":"110","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Xu, L., Li, A., & Han, X. (2019). The roles of ZEB1 in tumorigenic progression and epigenetic modifications. Biomedicine & Pharmacotherapy, 110, 400\u2013408. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.112","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"2106_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00345-016-1835-1","volume":"35","author":"RL Favaretto","year":"2017","unstructured":"Favaretto, R. L., Bahadori, A., Mathieu, R., et al. (2017). Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World Journal Of Urology, 35(1), 113\u2013120. https:\/\/doi.org\/10.1007\/s00345-016-1835-1","journal-title":"World Journal Of Urology"},{"issue":"5","key":"2106_CR27","first-page":"4503","volume":"8","author":"Z Liang","year":"2015","unstructured":"Liang, Z., Xie, W., Wu, R., et al. (2015). Inhibition of tobacco smoke-induced bladder MAPK activation and epithelial-mesenchymal transition in mice by curcumin. Int J Clin Exp Pathol, 8(5), 4503\u20134513. PMID: 26191140 PMCID: PMC4503012.","journal-title":"Int J Clin Exp Pathol"},{"key":"2106_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1756-9966-29-119","volume":"29","author":"Q Yu","year":"2010","unstructured":"Yu, Q., Zhang, K., Wang, X., Liu, X., & Zhang, Z. (2010). Expression of transcription factors Snail, Slug and Twist in human bladder carcinoma. J ExpClin Cancer Res, 29, 119. https:\/\/doi.org\/10.1186\/1756-9966-29-119","journal-title":"J ExpClin Cancer Res"},{"key":"2106_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s42399-018-0028-1","volume":"1","author":"R Singh","year":"2019","unstructured":"Singh, R., Mandhani, A., Agrawal, V., & Garg, M. (2019). Immunohistochemical studies to examine the diagnostic and prognostic implications of epithelial-to-mesenchymal transition in patients with urothelial carcinoma of the bladder. SN Comp Clin Med, 1, 277\u2013286. https:\/\/doi.org\/10.1007\/s42399-018-0028-1","journal-title":"SN Comp Clin Med"},{"key":"2106_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.urolonc.2007.12.012","volume":"27","author":"ME Fondrevelle","year":"2009","unstructured":"Fondrevelle, M. E., Kantelip, B., Reiter, R. E., Chopin, D. K., Thiery, J. P., Monnien, F., Bittard, H., & Wallerand, H. (2009). The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urologic Oncology, 27, 268\u2013276. https:\/\/doi.org\/10.1016\/j.urolonc.2007.12.012","journal-title":"Urologic Oncology"},{"key":"2106_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pathol-012513-104703","volume":"11","author":"B Bzerniak","year":"2016","unstructured":"Bzerniak, B., Dinney, C., & MacConkey, D. (2016). Origins of bladder cancer. Annual Review Of Pathology: Mechanisms Of Disease, 11, 149\u2013174. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104703","journal-title":"Annual Review Of Pathology: Mechanisms Of Disease"},{"key":"2106_CR32","doi-asserted-by":"publisher","unstructured":"Dr\u00e1pela, S., Bouchal, J., Jolly, M. K., Zoran, C., & Karel, S. (2020). ZEB1: A critical regulator of cell plasticity, DNA damage response, and therapy resistance. Frontiers in Molecular Biosciences, 7. https:\/\/doi.org\/10.3389\/fmolb.2020.00036","DOI":"10.3389\/fmolb.2020.00036"},{"issue":"20","key":"2106_CR33","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","volume":"69","author":"E S\u00e1nchez-Till\u00f3","year":"2012","unstructured":"S\u00e1nchez-Till\u00f3, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A., & Postigo, A. (2012). EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cellular And Molecular Life Sciences, 69(20), 3429\u20133456. https:\/\/doi.org\/10.1007\/s00018-012-1122-2","journal-title":"Cellular And Molecular Life Sciences"},{"key":"2106_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2741\/E853","volume":"11","author":"M Garg","year":"2019","unstructured":"Garg, M., & Singh, R. (2019). Epithelial-to-mesenchymal transition: Event and core associates in bladder cancer. Frontiers in Bioscience Elite, 11, 150\u2013165. https:\/\/doi.org\/10.2741\/E853","journal-title":"Frontiers in Bioscience Elite"},{"key":"2106_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12307-017-0199-4","volume":"11","author":"R Singh","year":"2018","unstructured":"Singh, R., Mandhani, A., Agrawal, V., & Garg, M. (2018). Positive correlation between matrix metalloproteinases and epithelial-to-mesenchymal transition and its association with clinical outcome in bladder cancer patients. Cancer Microenvironment, 11, 23\u201339. https:\/\/doi.org\/10.1007\/s12307-017-0199-4","journal-title":"Cancer Microenvironment"},{"key":"2106_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A., & Weinberg, R. A. (2019). New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nature Reviews Molecular Cell Biology, 20, 69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"2106_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee, S. H., Hu, W., Matulay, J. T., et al. (2018). Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell, 173(2), 515\u2013528e17. https:\/\/doi.org\/10.1016\/j.cell.2018.03.017.","journal-title":"Cell"},{"key":"2106_CR38","doi-asserted-by":"publisher","unstructured":"Minoli, M., Cantore, T., Hanhart, D. (2023). Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nat Commun. 14(1):2214. https:\/\/doi.org\/10.1038\/s41467-023-37696-2. PMID: 37072390; PMCID: PMC10113240.","DOI":"10.1038\/s41467-023-37696-2"},{"key":"2106_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.eururo.2024.08.020","volume":"86","author":"H Plage","year":"2024","unstructured":"Plage, H., Dressler, F., & Fendler, A. (2024). Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer. European Urology, 86, 445\u2013444. https:\/\/doi.org\/10.1016\/j.eururo.2024.08.020. Epub 2024 Aug 25. PMID: 39183091.","journal-title":"European Urology"},{"issue":"13","key":"2106_CR40","doi-asserted-by":"publisher","first-page":"e2414558","DOI":"10.1002\/advs.202414558","volume":"12","author":"H Zhao","year":"2025","unstructured":"Zhao, H., Lin, N., Ho, V. W. S., et al. (2025). Patient-Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment. Adv Sci (Weinh), 12(13), e2414558. https:\/\/doi.org\/10.1002\/advs.202414558.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02106-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02106-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02106-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:13:46Z","timestamp":1789632826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02106-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02106-z","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"10 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Studies were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Ethical clearance was obtained from Bioethics Cell, Institutional Ethics Committee (IEC) SGPGIMS, Lucknow, India (Reference no. 2014-166-CP-80).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Analysis used anonymous data that were obtained after each patient agreed to participate in the study. A written informed consent was taken from each patient or immediate family member.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}